Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program

other

Summary

The DREAMS grant will support The CureDuchenne International Outreach Program, which enhances global awareness and training on Duchenne through virtual and in-person conferences across various countries that may have limited access to education, healthcare and resources. The grant will play a key role in enabling the program to expand efforts to diagnose, treat and support individuals affected by Duchenne in Nepal, Uganda and China and other countries throughout 2024-2025. Walking Strongs programs are available to all Duchenne families and provide services such as free one-on-one mental wellness and life coaching, access to mobility and assistive devices, and canine support animals. Applicants are encouraged to demonstrate collaboration with minority-led or local community organizations to overcome barriers that limit the delivery of health education and support for individuals and families. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA-, antibody- and enzyme-based programs for the potential treatment of neuromuscular, ocular, metabolic and immunological diseases, among others.

Classifications

industries
No industries detected
applications
No applications detected

AskAI Classifications

Labels
No AI classifications detected

Linked Companies